{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:23:39Z","timestamp":1768713819962,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH"},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.parkreldis.2015.07.006","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T21:50:59Z","timestamp":1436565059000},"page":"1087-1092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk"],"prefix":"10.1016","volume":"21","author":[{"given":"Paola","family":"Costa-Mallen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus P.","family":"Zabetian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinky","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ching","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Yearout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Samii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Leverenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Checkoway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2015.07.006_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archneur.59.6.999","article-title":"Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury","volume":"59","author":"Berg","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1196\/annals.1306.025","article-title":"Iron out iron in Parkinson's disease and other neurodegenerative diseases with iron chelators. A lesson from 6-hydroxydopamine and iron chelators desferal and VK-28","volume":"1012","author":"Youdim","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.49.3.714","article-title":"Altered systemic iron metabolism in Parkinson's disease","volume":"49","author":"Logroscino","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1212\/WNL.0b013e3181bd80c1","article-title":"Anemia and low hemoglobin levels preceding Parkinson's disease: a case-control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jtemb.2005.08.003","article-title":"Calcium, copper, iron, magnesium, silicon and zinc content of hair in Parkinson's disease","volume":"19","author":"Forte","year":"2005","journal-title":"J.\u00a0Trace Elem. Med. Biol."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/mds.20826","article-title":"Blood donations, iron stores, and risk of Parkinson's disease","volume":"21","author":"Logroscino","year":"2006","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2015.07.006_bib8","first-page":"e1001462","article-title":"Serum iron levels and risk of Parkinson's disease: a Mendelian randomization study","volume":"10","author":"Pichler","year":"2013","journal-title":"P.Lo.S. Med."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0022-510X(94)90246-1","article-title":"Peripheral iron metabolism in patients with Parkinson's disease","volume":"125","author":"Cabrera-Valdivia","year":"1994","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s007020050073","article-title":"Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease","volume":"105","author":"Jim\u00e9nez-Jim\u00e9nez","year":"1998","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4615-8315-8_3","article-title":"Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation","volume":"12","author":"Bowman","year":"1982","journal-title":"Adv. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib13","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/clinchem\/46.10.1619","article-title":"The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males","volume":"46","author":"Langlois","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib14","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","article-title":"Biological and clinical significance of haptoglobin polymorphism in humans","volume":"42","author":"Langlois","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1423-0410.1965.tb01396.x","article-title":"The effect of haptoglobin-polymer size on hemoglobin binding capacity","volume":"10","author":"Javid","year":"1965","journal-title":"Vox. Sang."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib16","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood.V98.13.3693","article-title":"Structure-function analysis of the antioxidant properties of haptoglobin","volume":"98","author":"Melamed-Frank","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajmg.b.30593","article-title":"The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease","volume":"147","author":"Costa-Mallen","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","article-title":"Pooled analysis of tobacco use and risk of Parkinson disease","volume":"64","author":"Ritz","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1750-3639.2009.00296.x","article-title":"Association between lifetime cigarette smoking and Lewy body accumulation","volume":"20","author":"Tsuang","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/01.WNL.0000172630.22804.73","article-title":"A\u00a0clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations","volume":"65","author":"Zabetian","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib21","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.38.9.1402","article-title":"A\u00a0comparison of clinical and pathological features of young- and old- onset Parkinson's disease","volume":"38","author":"Gibb","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib22","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJM197505012921805","article-title":"Ferritin in serum. Clinical and biochemical implications","volume":"292","author":"Jacobs","year":"1975","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib24","first-page":"119","article-title":"Iron and ferritin in inflammation and cancer","volume":"10","author":"Torti","year":"1994","journal-title":"Adv. Inorg. Biochem."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.parkreldis.2010.02.007","article-title":"Iron and reactive oxygen species activity in parkinsonian substantia nigra","volume":"16","author":"Wypijewska","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.parkreldis.2006.10.002","article-title":"ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control","volume":"13","author":"Koziorowski","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.parkreldis.2015.07.006_bib28","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood-2003-09-3050","article-title":"Regulated secretion of glycosylated human ferritin from hepatocytes","volume":"103","author":"Ghosh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.parkreldis.2015.07.006_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/mgme.2000.3015","article-title":"Molecular heterosis: a review","volume":"71","author":"Comings","year":"2000","journal-title":"Mol. Genet. Metab."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015002916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015002916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T22:22:33Z","timestamp":1599258153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802015002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1353802015002916"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.07.006","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}